BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28843054)

  • 1. High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.
    Furtwängler R; Kager L; Melchior P; Rübe C; Ebinger M; Nourkami-Tutdibi N; Niggli F; Warmann S; Hubertus J; Amman G; Leuschner I; Vokuhl C; Graf N; Frühwald MC
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28843054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.
    van den Heuvel-Eibrink MM; van Tinteren H; Rehorst H; Coulombe A; Patte C; de Camargo B; de Kraker J; Leuschner I; Lugtenberg R; Pritchard-Jones K; Sandstedt B; Spreafico F; Graf N; Vujanic GM
    Pediatr Blood Cancer; 2011 May; 56(5):733-7. PubMed ID: 21370404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on relapses in unilateral nephroblastoma registered in 3 consecutive SIOP/GPOH studies - a report from the GPOH-nephroblastoma study group.
    Furtwängler R; Nourkami N; Alkassar M; von Schweinitz D; Schenk JP; Rübe C; Siemer S; Leuschner I; Graf N
    Klin Padiatr; 2011 May; 223(3):113-9. PubMed ID: 21509706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary lung metastases in pediatric malignant non-Wilms renal tumors: data from SIOP 93-01/GPOH and SIOP 2001/GPOH.
    Warmann SW; Nourkami N; Frühwald M; Leuschner I; Schenk JP; Fuchs J; Graf N
    Klin Padiatr; 2012 Apr; 224(3):148-52. PubMed ID: 22513793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant rhabdoid tumor of the kidney: significantly improved response to pre-operative treatment intensified with doxorubicin.
    Furtwängler R; Nourkami-Tutdibi N; Leuschner I; Vokuhl C; Niggli F; Kager L; Ebinger M; Frühwald MC; Graf N;
    Cancer Genet; 2014 Sep; 207(9):434-6. PubMed ID: 25242089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH).
    Furtwaengler R; Reinhard H; Leuschner I; Schenk JP; Goebel U; Claviez A; Kulozik A; Zoubek A; von Schweinitz D; Graf N;
    Cancer; 2006 May; 106(10):2275-83. PubMed ID: 16596620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children.
    Venkatramani R; Shoureshi P; Malvar J; Zhou S; Mascarenhas L
    Pediatr Blood Cancer; 2014 Aug; 61(8):1357-61. PubMed ID: 24789740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
    Koga Y; Matsuzaki A; Suminoe A; Hatano M; Saito Y; Kinoshita Y; Tajiri T; Taguchi T; Kohashi K; Oda Y; Tsuneyoshi M; Hara T
    Pediatr Blood Cancer; 2009 Jul; 52(7):888-90. PubMed ID: 19260106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
    Illhardt T; Ebinger M; Schwarze CP; Feuchtinger T; Furtwängler R; Schlegel PG; Klingebiel T; Greil J; Beck JF; Handgretinger R; Lang P
    Klin Padiatr; 2014 Nov; 226(6-7):351-6. PubMed ID: 25431868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Stage Dependent Necessity of Radiation Therapy in Rhabdoid Tumors of the Kidney (RTK).
    Melchior P; Dzierma Y; Rübe C; Graf N; Kager L; Dieckmann K; Kroiss S; Hubertus J; Warmann S; Schenk JP; Leuschner I; Nemes K; Meier CM; Vokuhl C; Frühwald M; Furtwängler R
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):667-675. PubMed ID: 32407933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
    Yamamoto M; Suzuki N; Hatakeyama N; Mizue N; Hori T; Kuroiwa Y; Hareyama M; Oda T; Kudoh T; Nui A; Matsuno T; Hirama T; Yokoyama S; Dome JS; Tsutsumi H
    J Pediatr Hematol Oncol; 2006 May; 28(5):286-9. PubMed ID: 16772877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
    Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
    Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study.
    Hempel L; Kremens B; Weirich A; Graf N; Zintl F; Ludwig R
    Klin Padiatr; 1996; 208(4):186-9. PubMed ID: 8776705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primitive neuroectodermal tumors of the brainstem in children treated according to the HIT trials: clinical findings of a rare disease.
    Friedrich C; Warmuth-Metz M; von Bueren AO; Nowak J; Bison B; von Hoff K; Pietsch T; Kortmann RD; Rutkowski S
    J Neurosurg Pediatr; 2015 Mar; 15(3):227-35. PubMed ID: 25555122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.
    Flentje M; Weirich A; Graf N; Pötter R; Zimmerman H; Ludwig R
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):163-9. PubMed ID: 9422573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
    Carli M; Colombatti R; Oberlin O; Stevens M; Masiero L; Frascella E; Koscielniak E; Treuner J; Pinkerton CR
    J Clin Oncol; 1999 Sep; 17(9):2796-803. PubMed ID: 10561355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
    Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
    J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor.
    Sultan I; Masarweh M; Ismael T; Al-Hussaini M; Almousa A; Ali HM; Rodriguez-Galindo C; Ghandour K
    J Pediatr Hematol Oncol; 2009 May; 31(5):333-8. PubMed ID: 19415012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.